Inactive Instrument
Quotes Epigenomics AG Deutsche Boerse AG
Stocks
DE000A0BVT96
Biotechnology & Medical Research
|
End-of-day quote
Deutsche Boerse AG
|
||
| - EUR | - |
|
| 04-02 | Epigenomics AG Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 25-07-22 | Epigenomics AG Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
Stock exchange
Deutsche Boerse AG- €
-
0
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| ECX | 0.9150EUR | +0.55% | 72.28 € | ||
Börse Stuttgart
| ECX | 0.9100EUR | 0.00% | 0 € | |
Boerse Muenchen
| ECX | 0.9500EUR | 0.00% | 0 € |
Basic data
Market Cap (EUR)
799,352
Market Cap (USD)
931,320
Net sales (EUR)
24,000
Net sales (USD)
27,962
Free-Float
70.75 %
Free-Float capitalization (EUR)
565,570
Free-Float capitalization (USD)
658,942
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | 0.00% | - | - | 931K | ||
| -0.34% | +2.63% | +104.38% | +324.68% | 4.19B | ||
| -4.27% | +1.13% | +229.80% | +31.38% | 3.82B | ||
| +0.57% | +4.98% | +52.36% | +74.16% | 3.54B | ||
| +0.31% | +9.57% | +297.81% | +483.73% | 2.63B | ||
| -2.91% | +4.01% | -26.20% | -20.95% | 2.32B | ||
| +1.52% | +2.64% | +32.48% | - | 1.5B | ||
| -1.11% | +23.27% | +267.77% | -14.42% | 1.34B | ||
| -2.18% | +3.80% | +19.81% | +45.60% | 1.03B | ||
| +1.68% | +22.01% | +34.48% | +180.72% | 678M | ||
| Average | -0.75% | +12.97% | +112.52% | +138.11% | 2.11B | |
| Weighted average by Cap. | -1.04% | +8.54% | +127.00% | +159.31% |
Historical Quotes: Epigenomics AG
| Date | Opening | High | Low | Close | Volume | Change |
|---|
- Stock Market
- Stocks
- ECX Stock
- Stock
- Quotes Epigenomics AG
Select your edition
All financial news and data tailored to specific country editions

















